Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 23, Number 4—April 2017

CME ACTIVITY - Synopsis

Transmission of Hepatitis A Virus through Combined Liver–Small Intestine–Pancreas Transplantation

This activity has been planned and implemented through the joint providership of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

Medscape, LLC designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 75% minimum passing score and complete the evaluation at http://www.medscape.org/journal/eid; and (4) view/print certificate.

Release date: March 15, 2017; Expiration date: March 15, 2018

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Analyze the epidemiology of hepatitis A virus (HAV) infection
  • Evaluate how organ donors are assessed for HAV infection
  • Evaluate laboratory results of the organ recipient and caregivers exposed to HAV infection in the current study.

CME Editor

Karen L. Foster, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Karen L. Foster has disclosed no relevant financial relationships.

CME Author

Charles P. Vega, MD, Clinical Professor of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, has disclosed the following financial relationships: served as an advisor or consultant for Allergan, Inc.; McNeil Consumer Healthcare; served as a speaker or a member of a speakers bureau for Shire Pharmaceuticals.

Authors

Disclosures: Monique A. Foster, MD, MPH; Lauren M. Weil, PhD, MPH; Sherry Jin, MD, MPH; Thomas Johnson, BS; Tonya Mixson-Hayden, PhD; Yury Khudyakov, PhD; Pallavi D. Annambhotla, DrPH; Sridhar V. Basavaraju, MD; Saleem Kamili, PhD; Jana M. Ritter, DVM; Noele P. Nelson, MD, PhD; George Mazariegos, MD; David T. Kuhar, MD; Matthew J. Kuehnert, MD; Jeffrey A. Miller, MD, MPH; Rachel Wiseman, MPH; and Anne C. Moorman, RN, MPH, have disclosed no relevant financial relationships. Michael Green, MD, has disclosed the following relevant financial relationships: served as an advisor or consultant for Chimerix, Bristol-Myers Squibb. Ryan W. Himes, MD, has disclosed the following relevant financial relationships: served as an advisor or consultant for Alexion; served as a speaker or a member of a speakers bureau for Alexion; received grants for clinical research from Alexion.

Article Navigation

TOP